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1. General experimental procedures
All reagents and chemicals were purchased from Sigma Aldrich, Carl Roth or Thermo Fischer Scientific. 
All solvents used for HPLC were analytical grade. General molecular biology procedures were 
performed according to standard protocols or following the manufacturer´s instructions in case of 
commercially obtained equipment/kits. For polymerase chain reaction either OneTag polymerase 
(NEB; analytical purposes) or Q5 polymerase (NEB; cloning purposes) was used. All restriction enzymes 
deployed in this study were obtained from NEB and used according to the manufacturer´s protocol. All 
media used was prepared in deionized water and sterilized at 126 °C for at least 20 min. NMR analysis, 
HRMS analysis and analytical as well as preparative LC/MS was performed as published previously. All 
concentrations are w/v unless otherwise specified. (1)
1.1. Bioinformatics
Pairwise sequence identities of proteins were determined using Clustal Omega in default settings.(2) 
The putative pvsch BGC was identified in the publicly available genome of P. verrucosum (NCBI: 
BioProject PRJNA276626). ORFs within the cluster were manually annotated using BLAST(3) and 
Softberry FGENESH 2.6(4) with default settings and using Penicillium chrysogenum as reference 
organism. Domain analysis of schPKS was performed using the InterPro(5) tool.
1.2. Media and solutions
 Czapek Dox with sorbitol (CD+S; Czapek Dox broth 3.5%, D-sorbitol 18.22%, agar 1.5%)
 Czapek Dox with sorbitol, soft agar (CD+S soft agar; Czapek Dox broth 3.5 %; D-sorbitol 18.22%; 
agar 0.8%)
 CD/S agar (3.5% Czapek Dox broth; 1 M sorbitol; 0.05% adenine; 0.15% methionine; 0.1% 
(NH3)2SO4)
 CZD/S agar (Czapek Dox broth 3.5%; D-sorbitol 18.22%; ammonium sulfate 0.10%; adenine 
0,05%; L-methionine 0.15%; agar 1.5%)
 CZD/S1 agar (-Met) (Czapek Dox broth 3.5%; D-sorbitol 18.22%; ammonium sulfate (0.10%; L-
methionine (optional) 0.15%; agar 1.5%)
 CZD/S softagar (Czapek Dox broth 3.5%; D-sorbitol 18.22%; ammonium sulfate 0.10%; adenine 
0.05%; L-methionine 0.15%; agar 0.80%)
 CZD/S1 (-Met) Softagar (Czapek Dox broth 3.5%; D-sorbitol 18.22%; ammonium sulfate 0.10%; 
L-methionine (optional) 0.15%; agar 0.8%)
 CD1 agar (Czapek Dox broth 3.5%; NaCl 4.68%; ammonium sulfate 0.10%; adenine 0.05%; L-
methionine 0.15%; agar 1.5%)
 CD2 agar (-Met) (Czapek Dox broth 3.5%; NaCl 4.68%, ammonium sulfate 0.10%; L-methionine 
0.15%; agar 1.5%)
 DPY (dextrin from potato starch 2%; polypeptone 1%; yeast extract 0.5%; KH2PO4 0.5%; MgSO4 
0.05%; agar 2.5%)
 LB agar (yeast extract 0.5%; tryptone 1%; NaCl 0.5%; agar 1.5%)
 Malt extract (ME; malt extract 1.28%; peptone ex soya 0.08%; glycerol 0.24%; detrin from 
potato starch 0.28%; agar 1.5%)
 M1D medium (Ca(NO3)2 1.2 mM; KNO3 0.79 mM; KCl 0.87 mM; MgSO4 3 mM; NaH2PO4 0.14 
mM; sucrose 87.6 mM; ammonium tartrate 27.1 mM; FeCl3 7.4 µM; MnSO4 30 µM; ZnSO4 8.7 
µM; H3BO3 22 µM; KI 4.5 µM; pH 5.5)
 PDB medium (potato infusion 200 g L-1; dextrose 20 g L-1; pH 5.1).
 PDB agar (potato infusion 200 g L-1; dextrose 20 g L-1; pH 5.1; agar 1.5%)
 Supplement mixture minus uracil (SM-URA; yeast nitrogen base 0.17%; (NH4)2SO4 0.5%; D(+)-
glucose monohydrate 2%; complete supplement mixture minus uracil 0.077%; agar 1.5%)
 YPAD (yeast extract 1%; tryptone 2%; D(+)-glucose monohydrate 2%; adenine 0.03%)
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1.3. Strains and culture conditions
Phomopsis sp. CMU-LMA was provided by Dr. Jamal Ouazzani. Typically, the fungus was cultured on 
PDB agar at 28 °C. Formation of spores was observed after 10 d cultivation and spore suspensions 
containing 25% glycerol allowed long-term storage at -80 °C. For secondary metabolite production 
Phomopsis sp. CMU-LMA was inoculated into PDB medium (pH 5.2) and kept at 28 °C, 110 rpm for up 
to 8d (in particular used for Phomopsis sp. CMU-LMA wildtype and all KO strains except Phomopsis sp. 
CMU-LMA ΔschR3). Alternatively, Phomopsis sp. CMU-LMA was inoculated into M1D medium and kept 
at 28 °C and static conditions for 10 d (for Phomopsis sp. CMU-LMA ΔschR3). Phomopsis KO strains 
were always cultivated alongside a WT strain as positive control. Aspergillus oryzae NSAR1 was 
typically cultured on DPY agar (28 °C). Spores were harvested after 7d and mixed with glycerol to a 
final concentration of 25%, allowing long-term storage at – 80 °C. For secondary metabolite production 
spores were inoculated into 500 ml baffled flasks containing 100 ml DPY medium and kept at 28 °C and 
110 rpm for 7d. E. coli TOP-10 cells were grown on solid or liquid LB medium supplemented with the 
appropriate selection marker. Typically, cultures were incubated at 37 °C and 225 rpm for 16 h. 
Glycerol stocks containing 50% glycerol (v/v) were prepared for long-term storage at -80 °C.  
Saccaromyces cerevisisae CEN.PK2 was cultured on YPAD agar at 30 °C for 2-3 d. Alternatively, a single 
colony was inoculated into 10 ml liquid YPAD medium and grown at 30 °C and 200 rpm for 16 h. 
1.4. Chemical analysis of cultures
Mycelia of Phomopsis sp. CMU-LMA WT and KO strains was blended in the supernatant of producing 
cultures. Cell debris was removed by filtration and the filtrate was extracted two times with ethyl 
acetate (filtrate : ethyl acetate 1:5). Organic layers were combined and dried over anhydrous MgSO4. 
Solvent was removed under reduced pressure and the crude extract was dissolved in acetonitrile for 
LC/MS analysis.
For Aspergillus oryzae NSAR1 mycelium and supernatant was separated by Büchner filtration. The 
supernatant was acidified to pH 2 (2M HCl), mixed with equal amounts of ethyl acetate and extracted 
twice. In parallel, the mycelium was stirred in acetone (100 ml per 100 ml culture) for 1h (RT) prior to 
evaporation of the solvent under reduced pressure. 100 ml ddH2O was added to the remaining 
mycelium fraction, acidified to pH 2 (2M HCl) and extracted twice with equal amounts of ethyl acetate. 
Combined ethyl acetate extracts from supernatant and cells were dried over anhydrous magnesium 
sulfate and organic solvent was removed in vacuo. Crude extracts were dissolved in methanol to a final 
concentration of 10 mg ml-1.
1.5. Isotopic feeding experiments
Sodium [1-13C]-labelled acetate was obtained from Sigma Aldrich. Subsequently, growing cultures of 
Phomopsis sp. CMU-LMA were supplemented with the labelled isotope to a final concentration of 
15 mM.
1.6. Yeast homologous recombination
Assembly of Knockout plasmids and expression plasmids was routinously achieved by yeast 
homologous recombination. The uracil auxotrophic S. cerevisiae CEN.PK2 strain was used. Typically, a 
single colony was inoculated into 10 ml YPAD medium and grown overnight at 30 °C and 160 rpm. This 
seed culture was mixed with 40 ml fresh YPAD medium and kept at 30 °C and 160 rpm for 4-5h. Next, 
the cells were collected by centrifugation and washed twice with ddH2O prior to final resuspension in 
1 ml ddH2O. 100 µL were centrifuged (13,000 x g, 4 ˚C, 1 min) and resuspended in the transformation 
solution (240 µL PEG 3350 (50% w/v), 36 µL LiOAC (1M), 50 µL denatured salmon sperm DNA (2 mg ml-
1) and 34 µL DNA master mix). The DNA master mix contained linearized vector and DNA insert with a 
5´and 3´overlap of 30 bp with the cut sites of the vector (fragments). Vectors were either linearized by 
NotI (pE-YA) or AscI (pTYGSarg/ade/met). The resulting mixture of DNA and yeast was incubated at 42 
°C for 50 min. After centrifugation (13,000 x g, 4 ˚C, 1 min) the pellet was resuspended in 1 ml ddH2O 
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and plated on SM-URA agar. After incubation at 30 °C for 2-3 days plasmid was isolated using the 
Zymoprep Yeast Plasmid Miniprep kit, transformed into E. coli TOP10 or E. coli ccdb cells, re-isolated 
from bacterial cells and submitted to DNA sequencing. DNA sequencing was performed by Eurofins 
Genomics.
1.7. Construction of Phomopsis sp. CMU-LMA knockout plasmids
KO-cassettes for gene disruption in Phomopsis sp. CMU-LMA were designed as displayed in 
supplementary figure S5. KO-cassettes were composed of three DNA fragments previously amplified 
by polymerase chain reaction: the hygromycin resistance cassette (here named HygR; comprising PgdpA 
+ hph, ∼ 4 KBp) and two gene specific sequences homologous to the target gene (Target Left TL and 
Target Right TR; each ∼ 1 KBp). HygR was designed to have overlaps with TL and TR at the 3´ and 5´ end 
respectively. TL and TR were designed to have additional overlaps with the destination vector pE-YA. 
Overlaps comprised 30 nt. The KO-cassette was cloned into the shuttle vector pE-YA by yeast 
homologous recombination. Primers used for the generation of KO plasmid are listed in supplementary 
table S8. Successful generation of KO plasmids was confirmed by DNA sequencing.
1.8. Construction of A. oryzae expression vectors
Total RNA was extracted from Phomopsis sp. CMU-LMA using oligo (dT) nucleotides and the RevertAid 
Premium Transcriptase kit (Thermo Fischer) was used according to the manufacturer´s instructions to 
transcribe RNA into cDNA. For schPKS the Maxima Reverse Transcriptase from NEB was used. Intron 
free cDNA was used for PCR amplification of biosynthetic genes. schPKS was assembled in the pE-YA 
vector and shuttled into the pTYGS expression vector by gateway cloning (Invitrogen Gateway LR 
Clonase II enzyme mix; manufacturer´s protocol with halved reaction scale). 
For assembly in pE-YA schPKS (about 8 kb) was amplified in four fragments, each about 2 kb. Yeast 
homologous recombination yielded plasmid KELIII02A(No2_3) and DNA sequencing identified the 
presence of four predicted introns, suggesting that the cDNA used for amplification was contaminated 
with traces of gDNA. To remove the introns schPKS was reassembled in pE-YA. For this, schPKS was 
amplified from KELIII02A(No2_3) in seven fragments, omitting the predicted intron sequences and 
yielding plasmid KELIII07. Sequencing revealed that introns were indeed absent but that a point 
mutation was present (insertion of alanine at position 2490) leading to an undesired frame shift. The 
point mutation was manually repaired by yeast homologous recombination using KpnI digested 
KELIII07 and an amplified patch from KELIII02A(No2_3) having the correct sequence (supplementary 
figure S40). Repaired plasmid KELIII08 was confirmed by sequencing and shuttled into the pTYGSarg 
expression plasmid, yielding KELIII08a, using gateway cloning. Yeast homologous recombination was 
used to clone the tailoring biosynthetic genes into the respective multigene expression vectors 
pTYGSarg/ade/met under control of a constitutive promoter (either peno, padh, pgdpA; see 
supplementary figure S41). Expression vector KELIII08C was revealed to possess two point mutations 
in schR3 causing a frame shift resulting in inactive schR3. This vector was only used in experiments 
lacking schR3. Details for construction of expression plasmids are outline in supplementary table S10 
and oligonucleotides are noted in supplementary table S11.
1.9. Transformation of Phomopsis sp. CMU-LMA
For transformation of Phomopsis sp. CMU-LMA a protoplast mediated protocol was established. 
Mycelia from growing plates was inoculated into 50 ml PDB medium and incubated at 28 °C in static 
conditions for up to 5d. Cells were collected by filtration through sterile miracloth. Protoplast 
formation was accomplished by digestion of young mycelia with a mixture of lysing enzymes extracted 
from Trichoderma harzianum (10 mg ml-1, Sigma Aldrich) and driselase from Basidiomycetes spp. (5 mg 
ml-1, Sigma Aldrich) in osmotic buffer (0.8 M NaCl). The protoplasting solution was kept at 30 °C for 2-
3 hours while being slowly inverted. Protoplasts were released from hyphal strands by careful pipetting 
followed by filtration through sterile miracloth. After centrifugation (3000 x g, 5 min, 4 ˚C) the pelleted 
protoplasts were resuspended in 100 µL Solution 1 (0.8M NaCl; 10 mM CaCl2; 50 mM Tris-HCl pH 7.5) 
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and the concentration was assessed microscopically using a hemocytometer. Typically, 10 µg DNA 
were added to the protoplast solution and after incubation on ice for 2 minutes 1 ml of Solution II (60% 
w/v PEG3350; 0.8M NaCl; 10 mM Tris-HCl pH 7.5) was added and incubated at RT for another 20 
minutes. Finally, 5 ml of molten CZD/S agar (at 50 °C) was added and the mixture was spread evenly 
on a 10 cm Petri dish. Plates were incubated at 28 °C overnight for cell wall regeneration and then 
overlayed with 10 ml CD agar containing Hygromycin B at 100 µg ml-1-. Emerging single colonies were 
transferred to secondary plates (CD agar with Hygromycin B at 100 µg ml-1). Colonies that grew 
healthily on secondary plates were transferred to medium without antibiotic and assessed for correct 
integration of the KO cassette.
1.10. Assessment of targeted gene disruption
Successful disruption of sch biosynthetic genes was confirmed using polymerase chain reaction. For 
this, gDNA was isolated from Phomopsis sp. CMU-LMA KO strains using the GenEluteTM Plant Genomic 
DNA Miniprep Kit (Sigma Aldrich). Two PCR reactions were performed on each sample and WT gDNA 
as control. Whole PCR (wPCR) reveals successful disruption as it amplifies the entire target gene 
cassette (in case of schPKS a 1 kbp region within the internal region that is deleted upon successful 
gene disruption). In case of WT gDNA wPCR gives the correct insert size. In case of KO strains wPCR 
yields a larger PCR product as the whole disruption cassette is amplified, including the hph resistance 
gene. External PCR (extPCR) reveals whether recombination occurred at the desired site: primers are 
designed to amplify from 5´ end of the hph resistance gene to genomic DNA flanking the target gene. 
extPCR only gives a product in case of successful disruption in the correct locus. It does not give a PCR 
product using WT gDNA, as WT gDNA lacks the hph gene. For wPCR the gene specific primers TL Fw 
and TR Re were used (compare oligonucleotides used for construction of KO plasmids). For external 
PCR validation gene specific primers (supplementary table S9) in combination with either primer 
HygRP7.2 Fw or HygRP6.2 Re (both binding to hygromycin gene cassette) were used.
1.11. Biotransformation of SCH 1 by Aspergillus oryzae NSAR1
Aspergillus oryzae NSAR1 from a sporulating DPY agar plated was inoculated into 500 ml baffled flasks 
containing 100 ml DPY medium and kept at 28 °C, 110 rpm for 2d. SCH 1 (7 mg) was dissolved in 1 ml 
DMSO, sterilfiltrated and added to the growing A. oryzae culture. After another 3d cultures were 
extracted and analysed as described above. Aspergillus oryzae NSAR1 WT fed with pure DMSO was 
used as a control experiment.
1.12. Transformation of Aspergillus oryzae NSAR1
A PEG-mediated transformation protocol was used for the ectopic integration of DNA into Aspergillus 
oryzae NSAR1. For this, conidia from a sporulating plate was inoculated into 100 ml GN medium 
(250 ml baffled flask) and kept at 30 °C, 180 rpm overnight. Mycelia was collected by filtration through 
sterile Miracloth and incubated in 10 ml protoplasting solution (20 mg ml-1 trichoderma lysing enzyme; 
sterilized by filtration through a 0.45 µm syringe filter) at 30 °C and 70 rpm for 3h. Gentle pipetting 
with a wide-bore pipette released the protoplasts from the hyphal strains. Protoplasts were collected 
by centrifugation (10 min, 3000 x g, 4 ˚C) and resuspended in solution 1 (100 µL per transformation; 
50 mM Tris-HCl pH 7.5; 800 mM NaCl; 10 mM CaCl2). After addition of 10 µL purified plasmid DNA the 
mixture was incubated on ice for 2 min prior to addition of 1 ml solution 2 (60% w/v PEG3350, 50 mM 
Tris HCl pH 7.5, 800 mM NaCl, 10 mM CaCl2). Additional incubation at room temperature for 20 min 
was followed by mixing with pre-warmed 5 ml CZD/S(1) softagar (-methionine) (50 °C) and overlayed 
onto pre-prepared CZD/S(1) plates (-methionine). Suitable agar was chosen according to auxotrophic 
resistance markers on the transformed plasmid DNA. All primary plates were kept at 28 °C for 3-5 days 
until visible formation of colonies. All colonies were subjected to two rounds of selection on arginine-
(adenine or methionine) deficient media, depending on the nature of auxotrophic markers present on 
transformed plasmids. Prior to fermentation single colonies were grown on DPY agar for 1 week. For 
every colony, gDNA was isolated and ectopic integration of DNA was checked by PCR using gene 































































Figure S3   A, BGC for Brefeldin A from P. brefeldianum. B, chain-lenth control of the hrPKS product 
of brefeldin A biosynthesis.(8)
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Figure S4
Figure S4   13C-NMR of labelled SCH 1 (top) in CDCl3 (125 MHz) compared to 13C-NMR of natural abundance SCH 1 (bottom).
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Figure S5
Figure S5   Construction of KO cassettes for targeted gene disruption in Phomopsis sp. CMU-LMA.
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Comment [CS]:  Ext. PCR data for PKS, 
schR1, schR2 missing. Do we need this?
Figure S6
Figure S6   PCR validation of gene disruption in Phomopsis sp. CMU-LMA. A, whole PCR; B, ext PCR.
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Figure S7
Figure S7   1H-NMR of compound 14 in CDCl3 (500 MHz).
14
Figure S8
Figure S8   13C-NMR of compound 14 in CDCl3 (500 MHz).
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Figure S9
Figure S9   COSY-NMR of compound 14 in Acetone-d6 (500 MHz).
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Figure S10
Figure S10   HSQC-NMR of compound 14 in Acetone-d6 (500 MHz).
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Figure S11
Figure S11   H-4 decoupling in 1H-NMR for compound 14 and determination of key coupling 
constants. A and B are identical with B being the enlarged region between 5.40 and 5.65 ppm of A.
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Figure S12




Figure S13   1H-NMR of compound 16 in CDCl3 (500 MHz).
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Figure S14
Figure S14   13C-NMR of compound 16 in CDCl3 (500 MHz).
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Figure S15
Figure S15   HSQC-NMR of compound 16 in CDCl3 (500 MHz).
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Figure S16 
Figure S16   COSY-NMR of compound 16 in CDCl3 (500 MHz).
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Figure S17
Figure S17   HMBC-NMR of compound 16 in CDCl3 (500 MHz
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Figure S18
Figure S18   Mass spectra (ES+) and UV chromatograms of 1, 17, 18.
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Figure S19
Figure S19   1H-NMR of compound 17 in CDCl3 (500 MHz).
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Figure S20
Figure S20   13C-NMR of compound 17 in CDCl3 (500 MHz).
27
Figure S21
Figure S21   HSQC-NMR of compound 17 in CDCl3 (500 MHz).
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Figure S22
Figure S22   COSY-NMR of compound 17 in CDCl3 (500 MHz).
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Figure S23
Figure S23   HMBC-NMR of compound 17 in CDCl3 (500 MHz)
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Figure S24
Figure S24   Mass spectra (ES+ and ES-) and UV chromatograms of 19 and 20.
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Figure S25
Figure S25   1H-NMR of compound 19 in CDCl3 (400 MHz)
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Figure S26
Figure S26   13C-NMR of compound 19 in CDCl3 (100 MHz)
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Figure S27
Figure S27   HSQC-NMR of compound 19 in CDCl3 (400 MHz)
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Figure S28
Figure S28   COSY-NMR of compound 19 in CDCl3 (400 MHz).
35
Figure S29
Figure S29   HMBC-NMR of compound 19 in CDCl3 (400 MHz).
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Figure S30
Figure S30   Thin-layer-chromatography (TLC) plate with one drop of each 16 and 19, stained with pH 
indicator Bromocresol green – a color change to yellow indicating an acid.
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Figure S31
Figure S31   Decoupling of H-7 in compound 19 1H-NMR (500 MHz)
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Figure S32
Figure S32   Decoupling of H-7 and H-10 in compound 19 1H-NMR (600 MHz)
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Figure S33
Figure S33   1H-NMR of compound 20 in DMSO-d6 (500 MHz).
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Figure S34
Figure S34   13C-NMR of compound 20 in DMSO-d6 (500 MHz).
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Figure S35
Figure S35   HSQC-NMR of compound 20 in DMSO-d6 (500 MHz).
42
Figure S36
Figure S36   COSY-NMR of compound 20 in DMSO-d6 (500 MHz).
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Figure S37
Figure S37   HMBC-NMR of compound 20 in DMSO-d6 (500 MHz).
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Figure S38
Figure S38   Chemical analysis of extracts from A. oryzae NSAR1 transformed with schPKS and schPKS 
+ schR1 compared to Aspergillus oryzae NSAR1 wt control. A, coexpresion of schPKS and schR1; B, 




Figure S39   Chemical analysis of extracts from A. oryzae NSAR1 transformed with full sch BGC 
omitting only schR1 and compared to Aspergillus oryzae NSAR1 wt control. A, transformed genes; B, 
DAD traces; C, ES+ traces
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Figure S40
Figure S40   Cloning strategy schPKS.
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Figure S41








Contigs (Scaffolded/Large (>500 Bp)/all) 5742/7578/28816
Bases in Scaffolds 64382824
Coverage 65.26 x
GC content (%) 52.92
Avg. Scaffold (Bp) 31529
N50 Scaffold 69395
Largest Scaffold 420401




Table S1   Assembly details of Phomopsis sp. CMU-LMA WT.
49
Table S2


























Position 𝛿C / ppm 𝛿H / ppm 𝛿C / ppm 𝛿H / ppm
CO2 1 166.1 - 166.7 -
CH=CH 2 118.2 5.91 (dd, 15.6, 1.8) 117.7 5.81 (dd, 15.6, 1.8)
CH=CH 3 148.2 7.03 (dd, 15.6, 4.5) 151.3 7.13 (dd, 15.6, 4.5)
CH-OH 4 68.5 5.27 (m) 68.5 5.26 (m)
CH=CH 5 132.0 5.54 (m) 132.9 5.45 (m)
CH=CH 6 131.2 5.46 (m) 132.8 5.36 (m)
CH-OH 7 70.6 4.82 (t) 70.5 4.82 (t, 16.0, 7.9, 3.4)
CH=CH 8 134.4 5.87 (m) 133.0 5.79 (m)
CH=CH 9 130.2 5.51 (m) 132.7 5.4 (m)
CH2 10a 32.8 2.08 (m) 33.6
10b 1.97 (m) 1.9 (m)
CH2 11a 24.4 1.82 (m) 25.5 1.79 (m)
11b 1.12 (m) 1.04 (m)
CH2 12a 34.5 1.75 (m) 35.2 1.7 (m)
12b 1.5 (m) 1.5 (m)
CH-OH 13 72.05 4.76 (m) 72.3 4.6 (m)
CH3 14 20.2 1.26 (d, 6.2) 20.6 1.2 (d, 6.2)
Table S3   NMR data compound 14 (CDCl3, 500 MHz).
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Table S4
Position 𝛿C / ppm 𝛿H / ppm
CO2 1 166.3 -
CH=CH 2 117.5 5.94 (dd, 15.7, 1.9)
CH=CH 3 149.6 7.18 (dd, 15.7, 3.9)
CH-OH 4 68.3 5.26 (m)
CH=CH 5 131.5 5.51 (m)
CH2 6 128.6 5.54 (m)
CH=CH 7 32.1 2.82 (m)
CH=CH 8 132.1 5.55 (m)
CH=CH 9 126.6 5.43 (m)
CH2 10a 32.9 2.08 (m)
10b 1.91 (m)
CH2 11a 24.4 1.78 (m)
11b 1.19 (m)
CH2 12a 34.3 1.74 (m)
12b 1.51 (m)
CH-OH 13 71.8 4.82 (m)
CH3 14 20.1 1.27 (d, 6.4)


















Compound 17 (1.2 mg, CDCl3, 500 MHz) Adelin et al. (2011), CDCl3
Atom 𝛿C  / ppm 𝛿H / ppm J / Hz 𝛿C  / ppm 𝛿H / ppm J / Hz
1 210.5 - - 211 - -
2a 35.8 2.24 dddd (14.3, 4.8, 2.4, 0.7) 35.8 2.2 m
2b 35.8 2.6 ddt (14.3, 6.4, 0.7) 35.8 2.66 m
3a 32.5 1.85 ddd (14.1, 4.8, 2.2) 32.5 1.78 m
3b 32.5 2.15 dddd (14.0, 6.1, 3.5, 2.3) 32.5 1.94 m
4 71.0 4.13 q (2.7) 70.9 4.1 m
5 41.8 2.37 dtd (12.1, 6.6, 2.2) 41.7 2.36 q (7.3)
6 47.0 2.66 m 47.8 2.66 m
7 22.1 1.47 m 21.2 1.35 m
8 22.7 1.20, 1.76 m 22.2 1.35 m
9 25.2 1.40, 1.60 m 22.7 1.35 m
10 33.2 1.35 m 33 1.35 m
11 74.1 5.1 m 74.1 5.07 m
12 173.2 - - 173.2 - -
13 39.7 2.60, 2.76 m, d (5.4) 39.8 2.66 m
14 19.7 1.26 d (6.4) 19.7 1.23 d (6.4)















Compound 19 (1.0 mg, DMSO, 500 MHz)
Atom 𝛿C  / ppm 𝛿H / ppm J / Hz 1H-1H COSY HMBC
1 167.4 - - - 2, 3
2 120.0 5.86 dd, 15.4, 1.6 3 1, 3, 4
3 149.1 6.67 dd, 15.4, 4.9 2, 4 1, 2, 4, 5
4 65.9 4.99 d, 6.2 3, 5 2, 3, 5, 6
5 131.0 5.29 m 6 3, 4, 6, 7
6 128.8 5.42 m 5, 7 4, 5, 7
7 30.4 2.79 m 6, 8 5, 6, 8, 9
8 130.9 5.39 m 7, 9, 10 6, 7, 9
9 127.5 5.42 m 10 10, 11
10 32.1 1.95 m 9, 11a, 11b, 12 9, 11
11a 25.3 1.36 m 10, 12 9, 10
11b 25.3 1.28 m 10, 12, 13 9, 10
12 38.6 1.28 m 10, 11 13, 14
13 65.6 3.56 m 12, 14 10, 11, 12, 14
14 23.7 1.02 d, 6.1 13 12, 13















Atom 𝛿C  / ppm 𝛿H / ppm J / Hz 1H-1H COSY HMBC
1 167.2 - - - 2, 3
2 119.6 5.86 dd, 15.6, 1.6 3 1, 3, 4
3 149.6 6.67 dd, 15.6, 4.9 2, 4 1, 2, 4, 5
4 65.8 4.99 m 3, 5 2, 3, 5, 6
5 131.0 5.28 ddt, 10.9, 8.2, 1.5 4, 6 3, 6, 7
6 128.7 5.44 m 5, 7 4, 5, 7
7 30.4 2.79 m 6 6, 8, 9
8 130.2 5.39 m 7, 9 7, 9
9 128.1 5.39 m 8, 10 7, 8, 10
10 30.3 1.93 m 9, 11 8, 9, 10, 11
11 23.0 1.50 p, 7.4 10, 12 9, 10, 12, 13
12 42.0 2.39 t, 7.3 11 10, 11, 13
13 208.3 - - - 11, 12, 14
14 29.7 2.06 S - 12, 13
Table S7   Chemical shifts of 1.9 mg 20 in DMSO.
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Table S8 
schPKS TL Fw GCCAACTTTGTACAAAAAAGCAGGCTCCGCATGCCTTCGTCATACATACA 
schPKS TL Re AAACGAAAGGCACAGAACAT 
schPKS HygR Fw CTCCTTTTCTATGTTCTGTGCCTTTCGTTTTCTAGTGGATCTTTCGACAC 
schPKS TR Fw CCCAGCACTCGTCCGAGGGCAAAGGAATAGGGGCGACGTCGCCAAGGAAG 
schPKS TR Re TGCCAACTTTGTACAAGAAAGCTGGGTCGGTCACGTAACAACCATCTTGG 
schR2 TL Fw GCCAACTTTGTACAAAAAAGCAGGCTCCGCAACCGGACATCTCGACACTC 
schR2 TL Re GGAACTCCGACTTCAGTCTG 
schR2 HygR Fw AGCTATGTCACAGACTGAAGTCGGAGTTCCTCTAGTGGATCTTTCGACAC 
schR2 TR Fw CCCAGCACTCGTCCGAGGGCAAAGGAATAGGACCCAGATAGAATTCCTGC 
schR2 TR Re TGCCAACTTTGTACAAGAAAGCTGGGTCGGCCAACTCCACATCCGACTTG 
schR3 TL Fw GCCAACTTTGTACAAAAAAGCAGGCTCCGCCAATATTCATGCTCTTGGGC 
schR3 TL Re AATCAGGGTATTCGAGAAAG
schR3 HygR Fw TATCATATGACTTTCTCGAATACCCTGATTTCTAGTGGATCTTTCGACAC 
schR3 TR Fw CCCAGCACTCGTCCGAGGGCAAAGGAATAGGACCCCGTTCACGACATCTA 
schR3 TR Re TGCCAACTTTGTACAAGAAAGCTGGGTCGGCGGGGTCAAATTTACAATAC 
schR4 TL Fw GCCAACTTTGTACAAAAAAGCAGGCTCCGCCAAATGATCTACCTCGGGAG 
schR4 TL Re CAAGCTCATGGTGCAGTATC 
schR4 HygR Fw CAGCTTCCATGATACTGCACCATGAGCTTGCTATTCCTTTGCCCTCGGAC 
schR4 TR Fw ACGTATTTCAGTGTCGAAAGATCCACTAGACTCTGTTCCAGTTTGCCATT 
schR4 TR Re TGCCAACTTTGTACAAGAAAGCTGGGTCGGCAGGTCTCAGTATCACTTTTC 
schR5 TL Fw GCCAACTTTGTACAAAAAAGCAGGCTCCGCGAGCAACAAACCATTCTGGT 
schR5 TL Re GTCCAGTTGGGAATGCCACT 
schR5 HygR Fw CCTGAGGACAAGTGGCATTCCCAACTGGACTCTAGTGGATCTTTCGACAC 
schR5 TR Fw CCCAGCACTCGTCCGAGGGCAAAGGAATAGCGTCCTTGCACATTCATGTC 
schR5 TR Re TGCCAACTTTGTACAAGAAAGCTGGGTCGGGATTGCCTAACTTCGTCTTC 
schR7 TL Fw GCCAACTTTGTACAAAAAAGCAGGCTCCGCGAACCCTTACTTTCAAAGCC 
schR7 TL Re GTAGAGGTCCTCGTGCTCAG 
schR7 HygR Fw GCATCTCCAACTGAGCACGAGGACCTCTACTCTAGTGGATCTTTCGACAC 
schR7 TR Fw CCCAGCACTCGTCCGAGGGCAAAGGAATAGGAGACATATACCGGGCCACT 
schR7 TR Re TGCCAACTTTGTACAAGAAAGCTGGGTCGGCATTTATTCGGCAAAGAGTC 
Table S8   Primers used for the construction of KO plasmids
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Table S9
HygRP7.2 Fw GCTTTCAGCTTCGATGTAGG 
HygRP6.2 Re CGTCAGGACATTGTTGGAG 
schPKS ext CTAGGCCTAGACTACTTGAC 
schR2 ext GAGAAAAGGCGATTTGAGTC 
schR3 ext GAATCACAAAGCCACCGTAATG 
schR5 ext GCATTAGCTCAACGGACC 
schR7 ext GCATTAGCTCAACGGACC 
Table S9   Primers used for external PCR in KO validation
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Table S10 
Construct ID Vector 
backbone
Template Oligonucleotides for construction in S. cervisiae
KELIII02A(No2_3)* pE–YA cDNA schPKS 4 fragments: P966-P973
KELIII07* pE–YA KELIII02A(No2_3) schPKS 7 fragments: P966+1103; P1104+1109, 
P1110+1079, P1080+1081, P1082+1083, P1084+1085, 
P1086+973
KELIII08 pE–YA KELIII02A(No2_3) Patch: P1104+1116; KELIII07 cut with KpnI 
KELIII02B pTYGSarg cDNA schR1: P975+976 
KELIII02C* pTYGSmet cDNA schR1: P975+977, schR2: P978+979, schR3*: P980+981
KELIII02D pTYGSmet cDNA schR4: P982+983, schR5: P984+985, schR7: P986+987 
KELIII08A pTYGSarg - LR with KELIII08 and KELIII02A
KELIII08B pTYGSarg - LR with KELIII08 and KELIII02B
KELIII08C* pTYGSarg - LR with KELIII08 and KELIII02C
KELIII10A pTYGSade KELIII08C, gDNA 
(schR3)
schR1: P975+977, schR2: P978+979, schR3: P980+981 
KELIII10B pTYGSade KELIII08C schR1: P975+977, schR2: P978+979, Patch_Peno: P87+88
KELIII10C pTYGSade KELIII08C schR1: P975+977, Patch_PgdpA: P91+92, schR3: P980+981
KELIII11A pTYGSmet KELIII02D Patch_PadH: P89+90, Patch_PgdpA: P91+92, schR7: 
P986+987
KELIII11B pTYGSmet KELIII02D Patch_PadH: P89+90, schR5: P984+985, schR7: P986+987
KELIII11C pTYGSmet KELIII02D schR4: P982+983, Patch_PgdpA: P91+92, schR7: P986+987 
KELIII15 pTYGSade KELIII10A Patch_PadH: P89+90, schR2: P978+979, schR3: P980+981 
*point mutations in gene
Table S10   Construction details for fungal transformation plasmids used for heterologous expression 











































Table S11   Oligonucleotides used in the construction of fungal expression vectors
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